Brief: Cellect Biotechnology Posts Qtrly Net Loss $0.01 Per Share And $0.12 Per Ads

Quoin Pharmaceuticals

19/11/2019 12:10

Nov 19 (Reuters) - Cellect Biotechnology Ltd  APOP.O :
    * CELLECT BIOTECHNOLOGY REPORTS THIRD QUARTER 2019 FINANCIAL
AND
OPERATING RESULTS
    * CELLECT BIOTECHNOLOGY LTD QTRLY  NET LOSS $0.01 PER SHARE
AND
$0.12 PER ADS
    * CELLECT BIOTECHNOLOGY LTD - "CONTINUES TO EVALUATE
BUSINESS
DEVELOPMENT OPPORTUNITIES"
    * CELLECT BIOTECHNOLOGY LTD - CONTINUE TO BELIEVE CO HAS
RESOURCES
TO EXECUTE CLINICAL AND REGULATORY PLANS FOR FORESEEABLE FUTURE
    * CELLECT BIOTECHNOLOGY LTD - EXPECTS TO COMPLETE
RECRUITMENT OF
PHASE 1/2 CLINICAL STUDY OF APOGRAFT AROUND END OF YEAR

Source text for Eikon:  ID:nPnb5Pgx8a 
Further company coverage:  APOP.O 

 ((Briefs@thomsonreuters.com;))